Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

The Botanicals Podcast

Dec 17 2021 | 00:13:40

00:00 / 00:13:40

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

Other Episodes

Episode 0

December 11, 2020 • 00:25:41

Hemp: 'An Economic Experiment on a Grand Scale'

JLN Editor Thom Thompson explains the twists and turns of the 2020 hemp market and looks ahead to 2021.

Episode 0

July 21, 2021 • 00:20:20

Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on...

Episode 1

May 07, 2020 • 00:15:55

JLN checks in with Supercritical on banking relief and a scramble for new canna licenses

In the latest JLN update on the legal cannabis marketplace, Thom Thompson interviews Sparky Rose and Kerry Jordan, principals of the consultancy Supercritical, about...